Ponesimod
Small Molecule
Overview
Ponesimod is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1096146).
Patent & exclusivity (US)
Per the FDA Orange Book (10 approved US products), the latest listed US patent on Ponesimod expires 10 Oct 2042 and exclusivity 18 Mar 2026. Generic API sourcing typically opens up once these lapse.
Verified Supplier Partner
Do you supply Ponesimod? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.